<DOC>
	<DOCNO>NCT01479166</DOCNO>
	<brief_summary>In plan study , 60 patient mild cystic fibrosis ( CF ) without involvement small airway ( small airway disease - SAD ) compare historical control group match age gender . During first study visit subject ask perform pulmonary function test ( spirometry , body plethysmography helium , determination `` Trapped Air '' ) exhale nitric oxide ( eNO ) exhale carbon monoxide ( eCO ) measurements do exhale air . In addition , blood sample drawn describe inflammatory status . Sputum induce well . During second study visit , non-specific bronchial provocation test ( methacholine PD20 FEV1 ) perform . The aim study get characterization bronchial systemic inflammation ( IL-1ß , IL-6 , IL-8 , IL-17 , TNF-α , NFKB , recognition structure like TLR2 TLR4 ) CF patient without involvement small airway , may point new treatment strategy .</brief_summary>
	<brief_title>Bronchial Inflammation Small Airways Patients With Cystic Fibrosis</brief_title>
	<detailed_description>Aim study characterization patient mild cystic fibrosis term lung function , bronchial hyperreactivity degree systemic bronchial inflammation . Sputum serum sample analyze quantitative real-time polymerase chain reaction ( qRT-PCR ) cytometric bead assay ( CBA ) . Components innate immune system ( mannose-binding protein , TLR recognition protein surfactant protein ) genetically determine sputum blood respectively . In order support analyze lung function sputum/ serum biomarker data investigator also rely pre-existing imaging data like chest x-rays high-resolution computer tomography ( HRCT ) lung . Methods Work Programme : This study consist two study visit ( V1 V2 ) V1 : Measurement nitric oxide exhale air ( eNO ) Measurement carbon monoxide exhale air ( eCO ) Lung function test spirometry body plethysmography Blood test : blood count , CRP , RAST , serum inflammatory mediator , genetic marker non-specific pulmonary defense system Induced sputum inflammatory mediator microbiological investigation V2 : Unspecific bronchial provocation test methacholine ( PD20 FEV1 methacholine ) Lung function test spirometry body plethysmography Study population : CF Children adult ( 6 - 60 year age ) healthy control group ( 6-60 year age ) . Both patient healthy subject recruit Christiane Herzog Cystic fibrosis outpatient clinic .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<criteria>informed consent confirm diagnosis CF ( know mutation and/or sweat chloride test &gt; 60mval/l ) age 6 60 year vital capacity &gt; 75 % Ability perform lung function test inhalation &lt; 6 &gt; 60 year age day write informed consent Acute illness systemic bronchial inflammation every chronic condition infection ( eg HIV , tuberculosis , malignancy ) pregnancy know alcohol and/ drug abuse Inability understand extent scope study Participation another study</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>cystic fibrosis</keyword>
	<keyword>HRCT</keyword>
	<keyword>Sputum</keyword>
	<keyword>Blood</keyword>
	<keyword>Inflammation</keyword>
	<keyword>adaptive immune system</keyword>
	<keyword>innate immune system</keyword>
</DOC>